up protherics
15 Jan 2018
Any Views Anyone Trading update WednesdayGreat sign stock falling ( NOT )INMO quantum holders were sold short with strike price over eleven pounds..INMO the results will show a high level of debt with not much growth achieved from the past six months..It said it all that Rigg resigned with immediate effect.Obviously realised that his share option package would be worth nothing over the next few years..Maybe worth shorting ???????
up protherics
02 Jan 2018
The Times Over the weekend the Times carried an article about how the market in unlicensed medicines had grownPersonally I think this could be either a positive or negative depending in what happens to this stock..Could explain to where we are now. This will either plumet or rocket during the next few months . Only my opinion..S dyor.. That's of course if there are Pi investors in this which is looking less and less likely as the days pa
up protherics
06 Dec 2017
Todays RNS HMMMMmmmmmm ???I am lost for wordsWhy wasn't he made to stay... Either they realised that he would be an overpaid director doing practically nothing.. Alternatively he realised that he made a big mistake either internally or selling QP out before they could show what they were capable of.I,d be interested in peoples views, but this being a bizaar share as no one seems to air any opinions on this either way..INMO.. This will either be a stellar share or the next p...pck.. So DYOR
up protherics
05 Dec 2017
Qp share holders Looks like QP shareholders have been very truly sucked in by the spiv brigade.Nice issue of equity together with the ramping of the price the day they were issued..INMO this stock was manipulated while the QP offer was going through and seems to be still manipulated afterwards to facilitate the chosen few.INMO two good companies have been sold out at a discounted offer for each one. One going overseas the other going into something which seems to be looking less credible by the day.
up protherics
18 Nov 2017
share options Are there any white crime lawyers out there. Preferably U,S ones and not the spiv brigade that are involved with envelope and his building brigadeGreat RNS INMOCould someone clarify.Share options handed out to the building brigade of Quantum with no initial strike price. HMMMMM.. All this handed out to a non qualifiedl CEO [ pharmaceutical industry ]Personally I have not financially gained by this takeover, but have gained valuable information as to how the spiv brigade now operates.. Hoodlems,gangsters and the 1920,s bootleggers spring to mind.Bring on MIFID two and the likes of envelope and his inquisitive with tax matters.Lets hope long prison sentences follow.
up protherics
15 Nov 2017
Oile Of Looks like this was over priced when they stitched up Qp shareholders.An I on my own thinking that the CEO together with his board only looked after themselves..What a surprise.I am little baffled as to what value he added.. A ten year old would have able to work out that closing a loss making devision to only focus on the profitable was the way forward.. He evidently could not add any value after doing the obvious.. So sold out when basically he had nothing to do and not being capable of taking the company forward.
up protherics
11 Nov 2017
Re: Any tax wizards out there? Base cost... I suggest you read the offer document ??????I don't see what the problem is you were evidently fortuitous enough to buy the shares in the first pla
evenlongershot
11 Nov 2017
Re: Any tax wizards out there? Base cost... the cash element is below what I paid so I can use the loss against other capital gains. It’s a calculation I still need to do whether it’s now or in the future, so having the base cost is still necessary to me. Anyone know what that base cost is please?
up protherics
10 Nov 2017
Re: Any tax wizards out there? Base cost Cli... In my viewYou wont be liable for any capital gains on the Clinigen shares until you sell themIf your cash element is the same or below than your original investment you will not be liable for capital gains. Anything above that is liable after you take your yearly allowance out.Around 10,000.Tax bands have also changed. Lower rate tax payer 10 percent and 20 percent on higher ra
evenlongershot
07 Nov 2017
Any tax wizards out there? Base cost Clinigen/apportionnent I want to work out the base cost and CGT situation on the QP takeover. I’m clear that receiving part cash for the takeover constitutes a disposal for CGT purposes, but how much do I apportion to the cash and how much to the new Clinigen shares? what percentage? And secondly is the value attributed to the Clinigen shares received, the closing price of Clinigen shares on 1 Nov when the deal completed?Thanks
Hydrogen Economy
07 Nov 2017
Commercial Officer Sells all shares There may be good reasons for Glass selling all his shares but seems a little unusual and a bit unsettling. SP on the slide in last few days, not sure if this contributed.Several board changes announced of late, but Mr. Glass not one of them.Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Company'), the global pharmaceutical and services group, announces that it was notified on 30 October 2017 that the following transaction took place on 30 October 2017. Steve Glass, Chief Commercial Officer, sold 17,360 ordinary shares of 0.1 pence each in the Company at a price of 1131 pence per share. Following this transaction, Mr Glass no longer holds any ordinary shares in the Company.
bushwhacker
21 Aug 2017
Cuurent Price With the price increasing toward the £11 recently due to the purchasing of Quantum Pharma I have decided to sell my shares today after several years of holding.I feel the company may now be overvalued for the time being, it has around £1 per shares worth of tangible assets, and £2 worth of equity within the company. Revenue only increased 7 % last year, although gross profit did increase 22%.This is not to say that the company is in excellent shape financially, and the management are obviously keen to expand its 'empire' with the prospect of adding Quantum Pharma. This is a good buy with obvious parallels to Clinigens own business, but Quantum Pharma did state a loss with write downs on deadwood business last year, and I still question the current business value with Quantum Pharma figures in the mix.Good luck to all owners of the share
MaX ProfOrdiS
16 Aug 2017
Re: Quantum Pharma From MoneyAM:Quantum Pharma plc is a growing manufacturer, supplier and service provider within the pharmaceutical sector. It is a market leader (in terms of its size or its service offering) in each of the niche markets in which it operates. Its customers include pharmaceutical wholesalers and retail pharmacies, hospitals, pharmaceutical companies, care homes and home care operators. Quantum's core business is the manufacture, procurement and supply to major UK pharmacy chains, wholesalers and hospitals of Specials and Special Obtains. Specials are medicines which are not licensed for general manufacture, which are prescribed for a specific patient need and which are manufactured or procured under an MHRA licence. Special Obtains are medicines and medicinal products that are difficult for pharmacies to source from a mainline pharmaceutical wholesaler. Quantum has a range of around 22,000 Special and Special Obtain products. It regularly services around 6,500 pharmacies and over 240 hospital accounts across the UK. Through acquisition and investment, Quantum has expanded into additional markets, including aseptic compounding and supplying home care and care home patients. The Group has gained access to overseas markets via U L Medicines Limited, significant product development and licensing expertise through Colonis Pharma Limited and has entered into a joint venture in the Republic of Ireland.
bushwhacker
16 Aug 2017
Quantum Pharma Does anyone know anything about Quantum Pharma?Clinigien proposed bid for the comapnay
II Editor
17 Jul 2017
NEW ARTICLE: Buy, hold, sell: Old Mutual UK Smaller Companies "Daniel Nickols, manager of the Old Mutual UK Smaller Companies fund, tells Marina Gerner which stocks he has been buying, selling and holding recently.Daniel Nickols has been the lead manager of FUND:A3I9:Old Mutual UK Smaller Companies since ..."[link]
